Despite the fact that omeprazole is one of the most widely prescribed drugs internationally, clinical professionals should enhance clinical risk management on adverse DDIs associated with omeprazole and ensure safe combination use of omeprazole by rationally prescribing alternatives, checking the appropriateness of physician orders before dispensing, and performing therapeutic drug monitoring.
72
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher, A. Liberati, Jennifer Tetzlaff et al. · BMJ · 2009 · 82.3K citations · Full text
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Deepak L. Bhatt, Byron Cryer, Charles F. Contant et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text